Unlock instant, AI-driven research and patent intelligence for your innovation.

A drug target for implant osseointegration in diabetic patients

A technology for diabetes and implants, which is applied in the field of biomedicine, can solve problems such as the unclear mechanism of insulin action, and achieve the effect of promoting osseointegration of implants

Active Publication Date: 2021-04-30
GENERAL HOSPITAL OF PLA
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the mechanism of action of insulin is still unclear

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A drug target for implant osseointegration in diabetic patients
  • A drug target for implant osseointegration in diabetic patients
  • A drug target for implant osseointegration in diabetic patients

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Example 1 Insulin Promotes Wound Healing Experiment

[0052] 1. Culture of THP-1 cells

[0053] Cells were cultured in complete medium (containing RPMI1640: FBS: streptomycin double antibody = 90:10:1, without B-mercaptoethanol), and the culture conditions were 37°C, 5% CO 2 The daily subculture operation is to draw the culture medium to a new culture bottle when the cells grow well under normal circumstances, and add a new medium; centrifuge the next day, centrifuge at 1000rpm for 3min, remove the old medium and wash with 1× PBS solution for 1 Then, centrifuge at 1000rpm for 3min, add new medium to continue passage.

[0054] 2. PMA induces THP-1 cell differentiation

[0055] Culture mononuclear cell line THP-1 cells, pass to the third generation, and use 5×10 6 Inoculate THP-1 cells in 12-well plate and culture in RPMI1640 medium containing 10% fetal bovine serum, 1% glutamine, 1% penicillin and streptomycin, using 60 μg / L myristyl phorbol acetate After (PMA) treat...

Embodiment 2

[0071] Example 2 Screening for genes related to osseointegration

[0072] 1. Cell culture

[0073] 1) The culture steps of THP-1 cells are the same as in Example 1;

[0074] 2) The step of PMA-induced THP-1 cell differentiation is the same as in Example 1;

[0075]3) The steps of treating macrophages with insulin are the same as in Example 1, and the concentration of insulin used is 200 ng / ml.

[0076] 2. Extraction of RNA

[0077] 1) Collection of cells

[0078] Remove the cell culture medium, wash once quickly with PBS buffer, remove the PBS buffer, and the adherent cells can be collected with a cell scraper. The collected cells were transferred to 1.5mL RNase-free EP tubes, and 3 tubes were taken for each group of cells as parallel samples.

[0079] 2) Add TRIzol Lysis Solution to the EP tube, so that the cells are completely dissolved in TRIzol and fully lysed;

[0080] 3) Transfer the lysate to a 1.5 mL RNase-free sterile centrifuge tube, add 200 μl chloroform, shak...

Embodiment 3

[0097] The overexpression of embodiment 3ZNF774 gene

[0098] 1. Cell culture and differentiation steps are the same as in Example 1

[0099] 2. Transfection

[0100] 1) Treatment of cells before transfection

[0101] The day before transfection, seed 3-5×10 on a 6-well culture plate 5 cells / well, cultured in antibiotic-free medium for one day, and replaced with serum-free medium before transfection.

[0102] 2) Construction of gene overexpression vector

[0103] Synthesize specific PCR amplification primers according to the ZNF774 sequence in GeneBank, and the primer sequences are as follows:

[0104] Forward primer: 5'-CCGGGTACCGCCACCATGT GGCTGGGGACTTC-3' (SEQ ID NO.1)

[0105] Reverse primer: 5'-CGGCTCGAGAATCAAATGGGTGTTTTGATGGC-3' (SEQ ID NO.2)

[0106] Two restriction enzyme sites, KpnI and XhoI, were added to the 5' end primer and the 3' end primer, respectively. The cDNA extracted and reverse-transcribed from a Parkinson's patient was used as an amplification temp...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a drug target for implant osseointegration of diabetic patients, and the drug target is ZNF774. The invention discloses a pharmaceutical composition, which comprises a promoter of ZNF774. The invention also discloses a method for screening candidate drugs for promoting osseointegration of implants in diabetic patients by using ZNF774.

Description

technical field [0001] The invention belongs to the field of biomedicine and relates to a drug target for implant osseointegration of diabetic patients, specifically the target is ZNF774. Background technique [0002] With the improvement of people's living standards and changes in lifestyle, the prevalence of diabetes is increasing year by year. When middle-aged and elderly people suffer from diabetes, they are often accompanied by dentition defect or loss. They are eager to benefit from dental implant technology. Artificial high implant technology has been carried out in my country for more than ten years, and has become one of the commonly used restoration methods for dentition defects or loss, especially the first choice for the restoration of missing teeth at the free end of the distal dentition. Implant osseointegration is the basis for the success of dental implants. However, many studies have confirmed that diabetes leads to delayed bone healing, which affects the su...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K45/00A61P19/08A61K49/00C12Q1/6883
CPCA61K45/00A61K49/0008A61P19/08C12Q1/6883C12Q2600/136C12Q2600/158
Inventor 汪林刘洪臣白阳
Owner GENERAL HOSPITAL OF PLA